Stock listing

Berry Genomics Co. Ltd. Class A

Selected listing: 000710 · SZSE · CNY · CN

Berry Genomics Co. Ltd. Class A (Shenzhen:000710), Health Technology. Latest release Nov 5, 2025: PacBio Announces Third Quarter 2025 Financial Results.

000710:SZSECNYCNUpdated October 2, 2026
Berry Genomics Co. Ltd. Class A logo
Ticker
Shenzhen:000710
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
Shenzhen
Currency
CNY

About Berry Genomics Co. Ltd. Class A

The company focuses on genomic research and biotechnology, contributing to advancements in healthcare and personalized medicine. Berry Genomics aims to enhance genetic testing and diagnostics in the region.

Latest news from Berry Genomics Co. Ltd. Class A

PacBio Announces Third Quarter 2025 Financial Results

November 5, 2025

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

November 4, 2025

All Berry Genomics Co. Ltd. Class A news →

Research Berry Genomics Co. Ltd. Class A

Berry Genomics Co. Ltd. Class A company profile

View the public company page for Berry Genomics Co. Ltd. Class A on 6ix.

Berry Genomics Co. Ltd. Class A news

Read company news and market updates connected to Berry Genomics Co. Ltd. Class A.

Berry Genomics Co. Ltd. Class A investor events

Find investor webinars, events, and replay context for Berry Genomics Co. Ltd. Class A.